FDA Inspection 1268559 — Sanxia Pharmaceutical (Hubei Yichang Xiaoting) Co., Ltd.
The FDA completed an inspection of Sanxia Pharmaceutical (Hubei Yichang Xiaoting) Co., Ltd. on March 21, 2025 in Yichang. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 21, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Yichang (China)